• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

破裂性肝细胞癌:一例报告

Ruptured Hepatocellular Carcinoma: A Case Report.

作者信息

Prasad Sonal, Xiong Jay, Abdelghani Loui

机构信息

Department of Internal Medicine, St. Joseph's Medical Center, Stockton, USA.

Department of Pulmonary and Critical Care Medicine, St. Joseph's Medical Center, Stockton, USA.

出版信息

Cureus. 2024 Jul 11;16(7):e64365. doi: 10.7759/cureus.64365. eCollection 2024 Jul.

DOI:10.7759/cureus.64365
PMID:39131004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11316844/
Abstract

Hepatocellular carcinoma (HCC) is one of the most common primary liver tumors in the world. In the United States, it is very uncommon for the liver mass to spontaneously rupture, especially if it has already been treated with embolization. Prompt diagnosis and treatment are necessary to improve the overall prognosis. Unfortunately, even with treatment, the patient can still rapidly decline. We present a case of a patient who was diagnosed with HCC and received treatment with transarterial radioembolization (TARE) with yttrium-90 (Y90). Despite this, the patient's liver mass grew and spontaneously ruptured. Although the patient received additional embolizations for his mass, he still deteriorated and eventually expired.

摘要

肝细胞癌(HCC)是全球最常见的原发性肝脏肿瘤之一。在美国,肝脏肿块自发破裂的情况非常罕见,尤其是在已经接受栓塞治疗的情况下。及时诊断和治疗对于改善总体预后至关重要。不幸的是,即使接受了治疗,患者仍可能迅速病情恶化。我们报告一例被诊断为HCC并接受钇-90(Y90)经动脉放射性栓塞(TARE)治疗的患者。尽管如此,患者的肝脏肿块仍在增大并自发破裂。尽管患者因其肿块接受了额外的栓塞治疗,但他的病情仍继续恶化,最终死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/11316844/01481f0343a2/cureus-0016-00000064365-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/11316844/bbdb9ab76525/cureus-0016-00000064365-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/11316844/d7462d45d30a/cureus-0016-00000064365-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/11316844/523af6eba8d6/cureus-0016-00000064365-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/11316844/8437df13110f/cureus-0016-00000064365-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/11316844/01481f0343a2/cureus-0016-00000064365-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/11316844/bbdb9ab76525/cureus-0016-00000064365-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/11316844/d7462d45d30a/cureus-0016-00000064365-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/11316844/523af6eba8d6/cureus-0016-00000064365-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/11316844/8437df13110f/cureus-0016-00000064365-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e8/11316844/01481f0343a2/cureus-0016-00000064365-i05.jpg

相似文献

1
Ruptured Hepatocellular Carcinoma: A Case Report.破裂性肝细胞癌:一例报告
Cureus. 2024 Jul 11;16(7):e64365. doi: 10.7759/cureus.64365. eCollection 2024 Jul.
2
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization.Y90 放射性栓塞治疗经动脉栓塞治疗后的肝细胞癌患者的结果。
Curr Oncol. 2024 May 8;31(5):2650-2661. doi: 10.3390/curroncol31050200.
3
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.钇-90经动脉放射性栓塞治疗肝细胞癌
Adv Ther. 2016 May;33(5):699-714. doi: 10.1007/s12325-016-0324-7. Epub 2016 Apr 2.
4
Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatric Hepatocellular Carcinoma.经肝动脉放射性栓塞治疗作为小儿肝细胞癌手术切除的桥梁。
J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1181-e1185. doi: 10.1097/MPH.0000000000002089.
5
Transarterial therapies in patients with hepatocellular carcinoma eligible for transarterial embolization: a US cost-effectiveness analysis.适合经动脉栓塞术的肝细胞癌患者的经动脉治疗:一项美国成本效益分析。
J Med Econ. 2023 Jan-Dec;26(1):1061-1071. doi: 10.1080/13696998.2023.2248840.
6
A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.肝细胞癌经动脉降期治疗的比较分析:化疗栓塞与放射性栓塞
Am J Transplant. 2009 Aug;9(8):1920-8. doi: 10.1111/j.1600-6143.2009.02695.x. Epub 2009 Jun 22.
7
Successful use of transarterial radioembolization with yttrium-90 (TARE-Y90) in two children with hepatoblastoma.成功应用钇-90 放射性微球动脉内放射栓塞术(TARE-Y90)治疗两名肝母细胞瘤患儿。
Pediatr Blood Cancer. 2020 Sep;67(9):e28421. doi: 10.1002/pbc.28421. Epub 2020 Jun 30.
8
Yttrium-90 microsphere radioembolotherapy in a patient with spontaneously ruptured hepatocellular carcinoma.钇-90微球放射性栓塞疗法治疗自发性破裂肝细胞癌患者
Clin Imaging. 2016 Jan-Feb;40(1):167-9. doi: 10.1016/j.clinimag.2015.08.011. Epub 2015 Aug 20.
9
Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study.影响肝细胞癌患者经动脉放射性栓塞术后生存的因素:前瞻性CIRT研究结果
JHEP Rep. 2022 Nov 25;5(2):100633. doi: 10.1016/j.jhepr.2022.100633. eCollection 2023 Feb.
10
Boosted-Dose Yttrium-90 Radiation Segmentectomy or Lobectomy for Hepatocellular Carcinoma Refractory to Prior Transarterial Embolization or Chemoembolization: A Single Institution Retrospective Case Series.高剂量钇-90放射节段切除术或肝叶切除术治疗既往经动脉栓塞或化疗栓塞难治性肝细胞癌:单中心回顾性病例系列
Cardiovasc Intervent Radiol. 2023 Apr;46(4):460-469. doi: 10.1007/s00270-023-03388-z. Epub 2023 Feb 28.

本文引用的文献

1
Prognostic Scores and Survival Rates by Etiology of Hepatocellular Carcinoma: A Review.肝细胞癌病因的预后评分与生存率:综述
J Clin Med Res. 2023 Apr;15(4):200-207. doi: 10.14740/jocmr4902. Epub 2023 Apr 28.
2
Spontaneously Ruptured Hepatocellular Carcinoma: Computed Tomography-Based Assessment.自发性破裂肝细胞癌:基于计算机断层扫描的评估
Diagnostics (Basel). 2023 Mar 7;13(6):1021. doi: 10.3390/diagnostics13061021.
3
Rupture of Hepatocellular Carcinoma: A Review of Literature.肝细胞癌破裂:文献综述
J Clin Exp Hepatol. 2019 Mar-Apr;9(2):245-256. doi: 10.1016/j.jceh.2018.04.002. Epub 2018 Apr 26.
4
Ruptured hepatocellular carcinoma following chemoembolization: a western experience.化疗栓塞后肝细胞癌破裂:西方经验
Hepatobiliary Pancreat Dis Int. 2007 Feb;6(1):49-51.
5
Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.
Radiology. 1996 Jan;198(1):33-40. doi: 10.1148/radiology.198.1.8539401.
6
Transcatheter arterial embolization for spontaneous rupture of hepatocellular carcinoma.经导管动脉栓塞术治疗肝细胞癌自发性破裂
Am J Gastroenterol. 1986 Apr;81(4):275-9.